Relationship of Substance P with the Degree of Atopic Dermatitis Severity

被引:7
作者
Paramita, Deryne Anggia [1 ]
Nasution, Khairina [1 ]
Lubis, Nova Zairina [1 ]
机构
[1] Univ Sumatera Utara, Fac Med, Dept Dermatol & Venereol, Sumatera Utara 20155, Indonesia
关键词
atopic dermatitis; SCORAD; substance P; pruritus;
D O I
10.2147/CCID.S306557
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Atopic dermatitis (AD) is a chronic inflammatory skin disease that starts during childhood with a varied course. Itching or incessant itching in severe cases, sleep disturbance, and infection-prone skin are the typical symptoms of this disease. Substance P is postulated to have an important role in AD. Increasing levels of substance P in AD induce the release of IFN-gamma, IL-4, tumor necrosis factor-alpha (TNF-alpha), and IL-10 from peripheral blood mononuclear leukocytes, inducing an itching response. Methods: This study is a cross-sectional study that aims to analyze the relationship between serum substance P levels and AD severity in children using Score of AD (SCORAD), and to determine the mean serum substance P levels and severity of AD in patients with AD. This study also aims to find out the correlation of substance P levels with the SCORAD values. Results: Forty-six children (29 males; 17 females) with a mean age of 10.35 years (standard deviation (SD) = 4.01) were diagnosed with AD. The SCORAD index assessment was conducted to analyze AD (mean value, 23.15; SD = 9.42), and mild AD obtained the highest degree. The level of substance P was also examined (mean value, 300.88; SD = 127.55). Discussion: This study did not find a significant relationship between substance P levels and AD severity (p-value = 0.880), and there was no significant correlation between substance P levels and SCORAD values (p-value = 0.233; r = -0.179). The limitations of this study include a small number of cases, no control group, and we only found two cases of severe AD. To generalize the results, further studies with wide range population and AD severity might be done in the future.
引用
收藏
页码:551 / 555
页数:5
相关论文
共 13 条
[1]   Skin neurogenic inflammation [J].
Choi, Jae Eun ;
Di Nardo, Anna .
SEMINARS IN IMMUNOPATHOLOGY, 2018, 40 (03) :249-259
[2]   Comparative efficacy of Hanifin and Rajka's criteria and the UK working party's diagnostic criteria in diagnosis of atopic dermatitis in a hospital setting in North India [J].
De, D. ;
Kanwar, A. J. ;
Handa, S. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2006, 20 (07) :853-859
[3]   Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride [J].
Hosokawa, Chisato ;
Takeuchi, Satoshi ;
Furue, Masutaka .
JOURNAL OF DERMATOLOGY, 2009, 36 (04) :185-190
[4]  
Lawton Sandra, 2013, Community Pract, V86, P46
[5]   New Insights into Atopic Dermatitis: Role of Skin Barrier and Immune Dysregulation [J].
Leung, Donald Y. M. .
ALLERGOLOGY INTERNATIONAL, 2013, 62 (02) :151-161
[6]   Research in practice: Substance P antagonism in chronic pruritus [J].
Lotts, Tobias ;
Staender, Sonja .
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2014, 12 (07) :557-559
[7]   Immunoregulatory Effects of Neuropeptides on Endothelial Cells: Relevance to Dermatological Disorders [J].
Mehta, Devina ;
Granstein, Richard D. .
DERMATOLOGY, 2019, 235 (03) :175-186
[8]  
Munawwarah L, 2017, PAEDIATR INDONES
[9]  
Patrizi Annalisa, 2011, J Allergy (Cairo), V2011, P279425, DOI 10.1155/2011/279425
[10]  
Simpson E. L., 2019, Fitzpatricks Dermatology, P363